Alameda Oscar Niemeyer, No. 119
Room 504 Vila da Serra
Nova Lima, MG
55 31 3515 7550
Sector(s): Consumer Defensive
Industry: Education & Training Services
|Mr. Virgilio Deloy Capobianco Gibbon||Chief Exec. Officer||N/A||N/A||1976|
|Mr. Luis Andre Carpintero Blanco||Chief Financial Officer||N/A||N/A||1973|
|Renata Couto||Investor Relations Exec. Mang.||N/A||N/A||N/A|
|Mr. Julio Eduardo Razente de Angeli||VP of Continuing Education & Innovation||N/A||N/A||1973|
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
Afya Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.